Showing 501 - 520 results of 5,248 for search '"Vascular endothelial growth factor"', query time: 0.20s Refine Results
  1. 501

    Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer. by Hanrahan, E, Ryan, A, Mann, H, Kennedy, S, Langmuir, P, Natale, R, Herbst, R, Johnson, B, Heymach, J

    Published 2009
    “… PURPOSE: Vandetanib [vascular endothelial growth factor (VEGF) receptor/epidermal growth factor receptor/RET inhibitor] has shown improvements in progression-free survival (PFS) in advanced non-small cell lung cancer in three randomized phase II studies: vandetanib versus gefitinib (study 3), docetaxel +/- vandetanib (study 6), and carboplatin-paclitaxel and/or vandetanib (study 7). …”
    Journal article
  2. 502
  3. 503
  4. 504
  5. 505
  6. 506
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514
  15. 515
  16. 516
  17. 517
  18. 518
  19. 519
  20. 520